Noticias de MRNA

Noticias del mercado

Últimas noticias sobre MRNA — 303 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: MRNA ✕ 303 resultados
04/03/2026 MRNA_US — Yahoo Finance
Is Moderna Stock Outperforming the Dow?
04/03/2026 MRNA_US — Seeking Alpha
The Sun Will Shine On Moderna Again - Initiating With A Buy
04/03/2026 MRNA_US — Yahoo Finance
Moderna to pay up to $2.25B to settle COVID vaccine patent matter
04/03/2026 MRNA_US — Yahoo Finance
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
03/03/2026 MRNA_US — NBC Boston
Moderna agrees to pay nearly $1B to settle COVID vaccine battle
03/03/2026 MRNA_US — Law360
Moderna To Pay At Least $950M To End COVID-19 Vax IP Fight
20/02/2026 MRNA_US — Reuters
BioNTech sues Moderna for patent infringement over COVID shots
20/02/2026 MRNA_US — TradingView
Moderna, Inc. SEC 10-K Report
19/02/2026 MRNA_US — Yahoo Finance
Moderna to Present at Upcoming Conferences in March 2026
19/02/2026 MRNA_US — Yahoo Finance
Moderna Stock Jumps After FDA Reverses Course on Flu Shot
18/02/2026 MRNA_US — Bloomberg
FDA Decides to Review Moderna’s Flu Shot in Surprise Reversal
18/02/2026 MRNA_US — ap.org
Moderna says the FDA will consider its new flu shot after resolving a public dispute
18/02/2026 MRNA_US — Yahoo Finance
Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
18/02/2026 MRNA_US — Contract Pharma ES ← EN
La FDA de EE. UU. iniciará una revisión de la vacuna contra la gripe de ARNm en investigación de Moderna
18/02/2026 MRNA_US — PBS
Moderna says FDA will now consider its new mRNA flu shot after initial refusal
18/02/2026 MRNA_US — The Guardian
FDA reverses course and will review Moderna’s mRNA-based flu vaccine
18/02/2026 MRNA_US — Reuters
Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial
17/02/2026 MRNA_US — simplywall.st
Moderna, Inc. (NASDAQ:MRNA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$40.90
17/02/2026 MRNA_US — Yahoo Finance
Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE
13/02/2026 MRNA_US — Yahoo Finance
Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates

Página 15 de 16

keyboard_arrow_up